Lucio's leprosy is characterized clinically by diffuse, generalized, erythematous infiltration with no nodules. Other clinicaI manifestations are rhinitis, alopecia, telangiectasia of face and chest, facial acne rosacea and livedo on the lower limbs. I -3 Sk:in smears for acid-fast bacilli are positive from any site, since bacterial infection is diffuse. The histopathology shows characteristic features of diffuse granuloma Virchow cell infiltration and new vascular formation. 1 • 2 This variety of leprosy may be accompanied by Lucio's phenomenon characterized by multiple and acute necrotizing lesions. 4 -7 Treatment with multi-drug therapy (rifampicin, dapsone and clofazimine) has proved satisfactory with clinicaI improvement. 1 -3 Corticosteroids are prescribed when Lucio's phenomenon is present.
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Case report
A 52-year-old white man from Crato-Ceará-Brazil presented to the outpatient dermatology clinic at Walter Cantideo University Hospital with erythematous sk:in lesions. He had a history of syphilis treated with penicillin 16 years earlier and focal glomerulosclerosis with nephrotic syndrome for 8 years. He was tak:ing prednisone (O·25-1·0 mg/kg/day), frusernide and ranitidine. Exarnination revealed diffusely erythematous and infiltrated sk:in; te1angiec tasia on face and chest; alopecia of chest; violet-erythematous livedo on lower limbs and coalescent yellow maculae of irregular surface on his enlarged nose. There was no nerve involvement.
Investigation showed: acid fast bacilli on three sk:in smears (chest wall, neck and thighs) and smears from ear lobe and elbow: bacteriological and morphological indexes were not performed because at the time of diagnosis, Brazil' s Health Ministry did not require them for diagnosis. Other tests included erythrocyte sedimentation rate (75 mm), ftuorescent trepone mal antibody [absorbed test (FfA-ABS) (-ve)], Veneral Disease Research Laboratory test (VDRL) (1:2), antinuclear antibody (-ve), Mitsuda (-ve), Medina (-ve), cryoglobulin (-ve), haemoglobin at the time of presentation (14·8 mg!dl), white cell count range at the time of presentation (9500/mm 3 ), serum creatinine (1·1 mg/dl) and serum glucose (80 mg/dl). Alanine and aspartate arninotransferases, complement, search for parasites in faeces and protein electrophoresis showed no abnormalities.
Skin biopsy from the nose revealed inftammatory infiltration with numerous bacilli and significant hyperplasia of sebaceous glands. Renal biopsy showed focal glomerulosclerosis. Three skin biopsies from chest, neck and thighs demonstrated the papillary layer of the dermis as a clear bando Deeper in the dermis, there was diffuse inftammatory infiltration with 'foamy' macrophages with no nodule formation. Vascular proliferation was visible under H&E staining and numerous bacilli forming globi were observed with Wade-Fite staining.
Multidrug therapy treatment was started and by 3 months there was rernission of erythema with wrinkling of the skin. Skin smears showed fragmented bacilli and a skin biopsy from the chest wall showed resolution of the inftammatory infiltration with numerous bacilli. After 2 years of multidrug therapy, the infiltration of skin had regressed and there was diffuse hyperpigmentation due to clofazirnine. Skin smears were negative. The nephropathy was well controlled with prednisone (0·25-1 mg/kg/day).
Discussion
The diagnosis of Lucio's leprosy is difficult because in many cases the patient has no clear signs of leprosy. In this case, other factors contributed to the diagnostic difficulty. Firstly, the association with rinophyma and telangiectasia obscured the clinicaI perception of leprosy. Secondly, the use of glucocorticoids to control renal disease probably altered the progression of leprosy, possibly inhibiting a Lucio's phenomenon. Thirdly, there was the probable wrong diagnosis of syphilis and treatment with penicillin 16 years ago; the patient had a positive Veneral Disease Research Laboratory test but negative ftuorescent treponemal antibody absorbed test, which is more specific. The patient probably already had Lucio' s leprosy at that time with a false positive VDRL test. There has been evidence that a false-positive VDRL with intense reactions occurs constantly in Lucio's leprosy. l , 3 A study carried out in Mexico demonstrated 16% of false-positive VDRL in the sera of 25 patients with diffuse lepromatous leprosy. 7 The diagnosis of this case was based on clinicaI and rnicroscopic features. Clinically, there was diffuse erythematous infiltrated skin, with telangiectasia, livedo on lower extrernities, alopecia in some areas of the skin and a long evolution without the appearance of definite nodules or plaques. On rnicroscopic exarnination, diffuse granulomatous, Virchow cell infiltration and new vessel formation were observed.
The occurrence of Lucio' s leprosy in countries other than Mexico and Costa Rica is rarely described, although there have been reports of cases in California, Louisiana, Hawaii and Minas Gerais-Brazi1. 1 , 2 , 5 It is interesting that this case was diagnosed in a patient from the city of Crato-Ceará-Brazil, which has a very high prevalence of leprosy. Thus it is possible that more cases of this form of leprosy are yet to be diagnosed.
